These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36091624)

  • 1. Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies-a Retrospective Bi-institutional Study.
    Mehta S; Kammar P; Patel A; Goswami G; Shaikh S; Sukumar V; Trivedi E; Bhatt A
    Indian J Surg Oncol; 2022 Sep; 14(Suppl 1):1-9. PubMed ID: 36091624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
    Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
    Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J
    Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
    Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.
    Tabchouri N; Buggisch J; Demtröder CR; Thiery J; Rezniczek G; Tempfer CB; Fischer B; Dogan C; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2021 Sep; 28(9):5275-5286. PubMed ID: 33471267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
    Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
    Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
    BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
    Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries.
    Račkauskas R; Baušys A; Lukšta M; Jurgaitis J; Paškonis M; Strupas K
    World J Surg Oncol; 2021 Aug; 19(1):236. PubMed ID: 34376191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study.
    Kurtz F; Struller F; Horvath P; Solass W; Bösmüller H; Königsrainer A; Reymond MA
    Gastroenterol Res Pract; 2018; 2018():2743985. PubMed ID: 30473706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis.
    Deban M; Châtelain J; Fasquelle F; Clerc D; Toussaint L; Hübner M; Teixeira Farinha H
    Pleura Peritoneum; 2023 Jun; 8(2):75-81. PubMed ID: 37304163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial.
    De Simone M; Vaira M; Argenziano M; Berchialla P; Pisacane A; Cinquegrana A; Cavalli R; Borsano A; Robella M
    Biomedicines; 2020 Apr; 8(5):. PubMed ID: 32365877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases.
    Balmer A; Clerc D; Toussaint L; Sgarbura O; Taïbi A; Hübner M; Teixeira Farinha H
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Foslund IT; von Magius SAV; Ainsworth AP; Detlefsen S; Fristrup CW; Knudsen AO; Mortensen MB; Tarpgaard LS; Jochumsen KM; Graversen M
    Pleura Peritoneum; 2024 Jun; 9(2):69-77. PubMed ID: 38948328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.